The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of metformin use in the outcomes of multiple myeloma patients post stem cell transplant.
 
Narjust Duma
No Relationships to Disclose
 
Jesus Vera Aguilera
No Relationships to Disclose
 
Jonas Paludo
No Relationships to Disclose
 
Yucai Wang
No Relationships to Disclose
 
Theodora Anagnostou
No Relationships to Disclose
 
Amie L. Fonder
No Relationships to Disclose
 
Francis Buadi
No Relationships to Disclose
 
Shaji Kumar
Honoraria - Kesios Therapuetics; Noxxon Pharma; Skyline Diagnostics
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Celgene (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Sanofi (Inst); Takeda (Inst)
 
Martha Lacy
No Relationships to Disclose
 
Suzanne R. Hayman
No Relationships to Disclose
 
Angela Dispenzieri
Consulting or Advisory Role - GlaxoSmithKline (Inst); Prothena (Inst)
Research Funding - Alnylam (Inst); Celgene (Inst); Janssen Oncology (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Pfizer; Prothena
 
Morie A. Gertz
Honoraria - Celgene; ION Pharma; Isis Pharmaceuticals; Med Learning Group; Millennium; Novartis; Onyx; Prothena; Research to Practice; Sandoz; Sanofi
Consulting or Advisory Role - Prothena
Travel, Accommodations, Expenses - Celgene; Novartis; Prothena
 
David Dingli
No Relationships to Disclose